Head of Scientific Evaluation @ (January 2022 - Present)
Investor Director @ (April 2022 - Present)
Scientific Advisor @ (December 2019 - Present)
Director @ (February 2014 - Present)
Fraser Murray Education
Alliance Manchester Business School
MBA (Distinction) (Business Administration and Management, General)
University of London
PhD (Neuroscience)
University of Strathclyde
BSc (Immunology and Pharmacology)
Fraser Murray Skills
Lifesciences
Neuropharmacology
Biopharmaceuticals
Business Development
Neuroscience
Drug Discovery
Biotechnology
Drug Development
Biomarkers
Pharmaceutical Industry
Pharmacology
In Vitro
Collaboration
CRO
Animal Models
Team Leadership
Pharmaceutical Research
In Vivo
Outsourcing
R&D
CRO Management
Immunology
Life Sciences
Neurology
R&D
Technology Transfer
Fraser Murray Summary
Fraser Murray, based in Oxford, GB, is currently a Chief Executive Officer at Pheno Therapeutics Ltd. Fraser Murray brings experience from previous roles at Advent Life Sciences, Tridek-One, Chronos Therapeutics and Woodyett Consulting. Fraser Murray holds a MBA (Distinction) in Business Administration and Management, General @ Alliance Manchester Business School. With a robust skill set that includes Lifesciences, Neuropharmacology, Biopharmaceuticals, Business Development, Neuroscience and more. Fraser Murray has 3 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Fraser Murray?
Find contact details for 700 million professionals.